DGI:Borreliose/Kutane Manifestation/Quellen
• RKI - Epidemiologisches Bulletin; RKI Ratgeber Lyme – Borrelien, 25.April 2019/Nr. 17
• Fingerle V et. al Lyme-Borreliose : Serologische und mikrobiologische Diagnostik und Differentialdiagnose, Dtsch Med Wochenschr 2020; 145; 29-34
• AWMF Leitlinie der Deutschen Dermatologischen Gesellschaft AWMF-Register-Nr. 013/044 Klasse: S2k „Kutane Lyme Borreliose“ https://www.awmf.org/uploads/tx_szleitlinien/013-044l_S2k_Kutane_Lyme_Borreliose_2016-05.pdf
• Henningsson AJ, Lager M, Brännström R, Tjernberg I, Skogman BH The chemokine CXCL13 in cerebrospinal fluid in children with Lyme neuroborreliosis European Journal of Clinical Microbiology & Infectious Diseases (2018) 37:1983-1991
• Podbielski A, Abele-Horn M, Herrmann M, Kniehl E, Mauch H, Rüssmann H (Hrsg.) MIQ Qualitätsstandards in der mikrobiologisch-infektiologischen Diagnostik MiQ 12 2017 Lyme Borreliose Elsevier
• AWMF Neuroborreliose – Leitlinien für Diagnostik und Therapie in der Neurologie, AWMF-Registernummer: 030/071https://www.awmf.org/uploads/tx_szleitlinien/030-071l_S3_Neuroborreliose_2018-4.pdf
• Kullberg BJ, Vrijmoeth HD, van de Schoor F, Hovius JW. Lyme borreliosis: diagnosis and management. BMJ 2020 May 26;369:m1041
• Nau R, Christen HJ, Eiffert H „Lyme Disease – Current State of Knowledge“ Dtsch Ärztebl Int 2009; 106(5): 72-82 (Diskussion: https://www.aerzteblatt.de/pdf.asp?id=65524)
• Rizzoli A, Hauffe HC, Carpi G, Vourc’h GI, Neteler M, Rosà R. Lyme borreliosis in Europe. Euro Surveill. 2011: 16(27):pii=19906. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleID=19906 (letzter Zugriff:)
• Editorial Introducing EU-wide surveillance of Lyme neuroborreliosis. Vol 392 August 11, 2018 https://www.thelancet.com/action/showPdf?pii=S0140-6736%2818%2931738-0 (letzter Zugriff:)
• Sykes RA, Makiello P. An estimate of Lyme borreliosis incidence in Western Europe. Journal of Public Health Vol. 39, No.1, pp. 74-81
• WHO Lyme Borreliosis (Lyme disease) https://www.who.int/ith/diseases/lyme/en
• (letzter Zugriff: )
• AWMF Neuroborreliose – Leitlinien für Diagnostik und Therapie in der Neurologie, AWMF-Registernummer: 030/071 https://www.awmf.org/uploads/tx_szleitlinien/030-071l_S3_Neuroborreliose_2018-4.pdf
• Strle F, Lusa L, Ružić-Sabljić E, et al. Clinical characteristics associated with Borrelia burgdorferi sensu lato skin culture results in patients with erythema migrans. PLoS One. 2013;8(12):e82132. Published 2013 Dec 26. doi:10.1371/journal.pone.0082132
• Stanek G, Fingerle V, Hunfeld KP, et al. Lyme borreliosis: clinical case definitions for diagnosis and management in Europe. Clin Microbiol Infect. 2011;17(1):69-79. doi:10.1111/j.1469-0691.2010.03175.x
• Berglund J, Eitrem R, Ornstein K, et al. An epidemiologic study of Lyme disease in southern Sweden. N Engl J Med. 1995;333(20):1319-1327. doi:10.1056/NEJM199511163332004
• Maraspin V, Cimperman J, Lotric-Furlan S, et al. Solitary borrelial lymphocytoma in adult patients. Wien Klin Wochenschr. 2002;114(13-14):515-523.
• Asbrink, E. (1993). "Acrodermatitis chronica atrophicans." Clin Dermatol 11(3): 369-375.
• Margos G, Vollmer SA, Cornet M, et al. A new Borrelia species defined by multilocus sequence analysis of housekeeping genes. Appl Environ Microbiol. 2009;75(16):5410-5416. doi:10.1128/AEM.00116-09
• Margos G, Wilske B, Sing A, et al. Borrelia bavariensis sp. nov. is widely distributed in Europe and Asia. Int J Syst Evol Microbiol. 2013;63(Pt 11):4284-4288. doi:10.1099/ijs.0.052001-0
• Kurokawa, C., Lynn, G.E., Pedra, J.H.F. et al. Interactions between Borrelia burgdorferiand ticks. Nat Rev Microbiol18, 587–600 (2020). https://doi.org/10.1038/s41579-020-0400-5
• Fingerle V, Schulte-Spechtel UC, Ruzic-Sabljic E, et al. Epidemiological aspects and molecular characterization of Borrelia burgdorferi s.l. from southern Germany with special respect to the new species Borrelia spielmanii sp. nov. Int J Med Microbiol. 2008;298(3-4):279-290.